Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
MASI · 10-Q filed May 5, 2026

MASI earnings analysis

What we found in MASI's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

Masimo Corporation reported Q1 2026 earnings with revenues of $403.6M, an increase of 8.5% from Q1 2025's $372M, driven by strong consumables and service revenue. Gross margin fell slightly to 62.1% from 62.9%, and operating income was $77.4M, slightly down from $78.0M in the prior year. There was a net income of $57.1M compared to a loss of $170.7M in the previous year, marking a significant recovery.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Strong Revenue Growth
Revenue grew to $403.6M, an 8.5% increase from $372.0M in Q1 2025.
Positive Net Income
Net income reached $57.1M, a substantial turnaround from a loss of $170.7M in the prior year.
High Gross Margin
Despite a slight decline, gross margin remained robust at 62.1%.
Increased Operating Income
Operating income was $77.4M, just slightly below last year's $78.0M.
Robust Cash Flow from Operations
Cash provided by operating activities was $46.8M, an increase from $37.9M in Q1 2025.
Effective Management of Tariffs
Incremental tariffs incurred were $6.7M, managed through operational efficiencies.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Increased Costs from Tariffs
Incremental tariffs increased costs by $6.7M, which may affect future profitability.
Cybersecurity Incident Impact
A cybersecurity incident impacted operations; though recovered, risks remain.
Merger-Related Expenses
Transaction-related costs from the Danaher merger incurred approximately $17.9M.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $38 Operating expenses $43 Left as operating profit $19
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$1.36
Gross margin
62.1%
Operating margin
19.2%
Segment
Healthcare
Segment
OEM
Guidance

What they said about what is next.

Outlook deferred to earnings press release / call.

How we read the filing overall

The filing reads better than the one before it.

One reading of one document. It is not advice, and it is not a forecast.
Earlier filings

What came before.

10-K · May 1, 2026
Masimo's 10-K for the fiscal year ended January 3, 2026 reveals significant operational transitions, including an ongoing merger with Danaher Corporation, which could impact corporate strategy and financial positioning.…
10-K · February 27, 2026
Masimo’s 2026 Form 10-K is dominated by the proposed Merger with Danaher (Merger Agreement dated February 16, 2026) that would pay $180.00 per share in cash and creates material transaction-related risks and costs…
10-Q · November 4, 2025
Masimo reported Q3 revenue of $371.5M, up $28.2M (+8.2%) versus Q3 2024 ($343.3M), with gross profit of $230.6M (62.1% gross margin) and operating income of $83.6M (22.5% operating margin). Continuing operations…
10-Q · May 6, 2025
Masimo reported quarterly revenue of $372.0 million, up from $339.6 million a year earlier, with gross margin expanding to 62.9% and operating income rising to $78.0 million. Continuing operations delivered diluted…

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing MASI makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever